Application | Comment | Organism |
---|---|---|
drug development | unique cleavage preferences of the Dengue virus protease promise novelty for the design of potent inhibitors that may be selective for the flaviviral proteases over proteases of the host cell and thus provide a solid base for follow-on structural and functional studies | Dengue virus type 2 |
drug development | unique cleavage preferences of the West Nile virus protease promise novelty for the design of potent inhibitors that may be selective for the flaviviral proteases over proteases of the host cell and thus provide a solid base for follow-on structural and functional studies | West Nile virus |
Cloned (Comment) | Organism |
---|---|
into the pET101 and expressed in Escherichia coli BL21(DE3) Codon Plus cells | West Nile virus |
Protein Variants | Comment | Organism |
---|---|---|
H51A | devoid of any proteolytic activity and incapable of autolytically cleaving either the NS2B sequence or the NS3pro-hel boundary. Resistant to the proteolysis in trans by the external, highly active NS2B-NS3pro construct | West Nile virus |
K48A | mutation of the C-terminal amino acid residue of the NS2B sequence, inactivates the autolytic cleavage site. Does not have any significant effect on the catalytic activity. Readily cleaved in cis by the integral NS2B-NS3pro activity | West Nile virus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.036 | - |
t-butoxycarbonyl-Arg-Val-Arg-Arg-7-amido-4-methylcoumarin | mutant K48A | West Nile virus | |
0.04 | - |
t-butoxycarbonyl-Arg-Val-Arg-Arg-7-amido-4-methylcoumarin | wild-type | West Nile virus | |
0.059 | - |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin | mutant K48A | West Nile virus | |
0.071 | - |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin | wild-type | West Nile virus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Dengue virus type 2 | - |
- |
- |
Dengue virus type 2 16681 | - |
- |
- |
West Nile virus | - |
- |
- |
West Nile virus NY99 | - |
- |
- |
Purification (Comment) | Organism |
---|---|
recombinant DV NS2B-NS3pro, C-terminally tagged with a hexahistidine tag, purified by Co2+ affinity chromatography | Dengue virus type 2 |
wild-type and mutant NS2B-NS3pro and NS2B-NS3prohel constructs, C-terminally tagged with a hexahistidine tag, purified by Co2+ affinity chromatography | West Nile virus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | strict substrate specificity, the (K/R)(K/R)R-GG amino acid motif is optimal. Efficiently cleaves peptides derived from the West Nile virus and Dengue virus capsid protein C, from the NS2A/NS2B junction region and NS4B/NS5 junction region and from NS2B/NS3 | West Nile virus | ? | - |
? | |
additional information | strict substrate specificity, the (K/R)(K/R)R-GG amino acid motif is optimal. Efficiently cleaves peptides derived from the West Nile virus and Dengue virus capsid protein C, from the NS2A/NS2B junction region and NS4B/NS5 junction region and from NS2B/NS3 | West Nile virus NY99 | ? | - |
? | |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O | - |
West Nile virus | ? | - |
? | |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O | - |
Dengue virus type 2 | ? | - |
? | |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O | - |
Dengue virus type 2 16681 | ? | - |
? | |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O | - |
West Nile virus NY99 | ? | - |
? | |
t-butoxycarbonyl-Arg-Val-Arg-Arg-7-amido-4-methylcoumarin + H2O | - |
West Nile virus | ? | - |
? | |
t-butoxycarbonyl-Arg-Val-Arg-Arg-7-amido-4-methylcoumarin + H2O | - |
West Nile virus NY99 | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
NS2B-NS3 protease | - |
West Nile virus |
NS2B-NS3 protease | - |
Dengue virus type 2 |
NS2B-NS3 serine proteinase | - |
West Nile virus |
NS2B-NS3 serine proteinase | - |
Dengue virus type 2 |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.18 | - |
t-butoxycarbonyl-Arg-Val-Arg-Arg-7-amido-4-methylcoumarin | mutant K48A | West Nile virus | |
0.22 | - |
t-butoxycarbonyl-Arg-Val-Arg-Arg-7-amido-4-methylcoumarin | wild-type | West Nile virus | |
5.3 | - |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin | mutant K48A | West Nile virus | |
6.3 | - |
pyroglutamic acid-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin | wild-type | West Nile virus |